Acute MOG-IgG–associated myelitis in a patient with long-standing multiple sclerosis: a case report

Introduction: Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) and multiple sclerosis (MS) are distinct inflammatory demyelinating disorders that may share overlapping clinical and imaging features, creating important diagnostic challenges. Case Presentation: We describe a 58-year-old woman with unequivocal long-standing relapsing–remitting MS fulfilling established diagnostic criteria, including typical periventricular and deep white matter lesions on magnetic resonance imaging (MRI) and clear dissemination in space and time, with characteristic brain and spinal MRI findings and more than a decade of clinical and MRI stability under extended-interval natalizumab therapy. Following a febrile prodrome, she developed acute severe myelitis with rapid progression from baseline paraparesis (Expanded Disability Status Scale [EDSS] 6.0) to near-complete paraplegia (EDSS 8.0) within seven days. Cerebrospinal fluid analysis revealed marked pleocytosis, elevated protein levels, and absence of oligoclonal bands, findings atypical for MS relapse. Serum testing demonstrated high-titre MOG immunoglobulin G antibodies, which progressively declined and became negative during follow-up. Retrospective spinal cord MRI revealed transient central grey matter involvement with a characteristic H-sign on axial T2-weighted sequences, consistent with MOGAD-associated myelitis. The patient responded to high-dose intravenous corticosteroids and returned to baseline disability within three months. Conclusion: This case highlights that acute neurological deterioration in patients with established MS should not automatically be attributed to disease reactivation and supports careful consideration of alternative inflammatory demyelinating processes such as MOGAD when clinical, cerebrospinal fluid, and imaging features are atypical. Integration of clinical findings, cerebrospinal fluid analysis, MRI features, and antibody testing is essential to avoid diagnostic anchoring and ensure appropriate management.

Authors

Publication Details

Journal
Case Reports in Neurology
Published
2026-05-18
DOI
https://doi.org/10.1159/000552322
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Acute MOG-IgG–associated myelitis in a patient with long-standing multiple sclerosis: a case report

Iñigo Vicente-Olabarría, Aranzazu Pacho de Lucas, José Luis Sánchez-Menoyo, Miriam Cortés-Rubiales et al.
Case Reports in Neurology
Multiple Sclerosis Research Studies
article

Acute MOG-IgG–associated myelitis in a patient with long-standing multiple sclerosis: a case report

Iñigo Vicente-Olabarría, Aranzazu Pacho de Lucas, José Luis Sánchez-Menoyo, Miriam Cortés-Rubiales, Ana Cristina Pinedo-Brochado
article en

Abstract

Introduction: Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) and multiple sclerosis (MS) are distinct inflammatory demyelinating disorders that may share overlapping clinical and imaging features, creating important diagnostic challenges. Case Presentation: We describe a 58-year-old woman with unequivocal long-standing relapsing–remitting MS fulfilling established diagnostic criteria, including typical periventricular and deep white matter lesions on magnetic resonance imaging (MRI) and clear dissemination in space and time, with characteristic brain and spinal MRI findings and more than a decade of clinical and MRI stability under extended-interval natalizumab therapy. Following a febrile prodrome, she developed acute severe myelitis with rapid progression from baseline paraparesis (Expanded Disability Status Scale [EDSS] 6.0) to near-complete paraplegia (EDSS 8.0) within seven days. Cerebrospinal fluid analysis revealed marked pleocytosis, elevated protein levels, and absence of oligoclonal bands, findings atypical for MS relapse. Serum testing demonstrated high-titre MOG immunoglobulin G antibodies, which progressively declined and became negative during follow-up. Retrospective spinal cord MRI revealed transient central grey matter involvement with a characteristic H-sign on axial T2-weighted sequences, consistent with MOGAD-associated myelitis. The patient responded to high-dose intravenous corticosteroids and returned to baseline disability within three months. Conclusion: This case highlights that acute neurological deterioration in patients with established MS should not automatically be attributed to disease reactivation and supports careful consideration of alternative inflammatory demyelinating processes such as MOGAD when clinical, cerebrospinal fluid, and imaging features are atypical. Integration of clinical findings, cerebrospinal fluid analysis, MRI features, and antibody testing is essential to avoid diagnostic anchoring and ensure appropriate management.

Case Reports in Neurology
Gender equality, Good health and well-being
Openalex Percentile: Top 6%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Acute MOG-IgG–associated myelitis in a patient with long-standing multiple sclerosis: a case report — Iñigo Vicente-Olabarría, Aranzazu Pacho de Lucas, et al. · Case Reports in Neurology (2026) | TGRS Research Map | TGRS